Income Tax - Biotechnology Investment Incentive Tax Credit Program - Pass-Through Entities
Sponsor: Mark S. Chang (District 32)Committee: Ways and MeansSubject: Taxes - IncomeStatus: Hearing 2/15 at 1:00 p.m. (as of Nov 13, 2024)
What this bill does
Official synopsis
Allowing a qualified investor that is a pass-through entity that pays a certain income tax on behalf of its members to receive and allocate in any manner a credit or refund of a credit under the Biotechnology Investment Incentive Tax Credit Program; applying the Act to all taxable years beginning after December 31, 2023; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (7)
MGA witness listFAV 6FavorableINFO 1Information only
| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Carolan, Howard | CoapTech | Written (PDF) |
| FAV | Hemingway, Deborah | Ecphora Capital | Written (PDF) |
| FAV | Winder, Jason | Sonogen Medical | Written (PDF) |
| FAV | Delegate Chang, Delegate Changlegislator | Individual | Oral |
| FAV | Storey, Bob | Individual | Written (PDF) |
| FAV | Vetter, Drew | Individual | Written (PDF) |
| INFO | Hayes, Justin | Comptroller of Maryland | Written (PDF) |